The role of ochratoxin A as a possible cause of Balkan endemic nephropathy and its risk evaluation

Veterinary and Human Toxicology

Volumn 40, Issue 6, 1998, Pages 352-360

  Stoev, S D ^a  

^a TRAKIA UNIVERSITY   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOTOXIN; OCHRATOXIN;

ANTIGENICITY; ARTICLE; DRUG ELIMINATION; ENDEMIC DISEASE; ENVIRONMENTAL EXPOSURE; FOOD INTAKE; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY FUNCTION; KINETICS; METABOLISM; MORPHOLOGY; RISK ASSESSMENT; ULTRASTRUCTURE;

ANIMALS; BALKAN NEPHROPATHY; EUROPE, EASTERN; HUMANS; KIDNEY; MYCOTOXINS; OCHRATOXINS; RISK FACTORS;

SUIDAE;

EID: 0031733769     PISSN: 01456296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (90)

1. Ahmeteli M: Epidemologia endemiceskoj nephropatii. Sov Medicina 5: 123-128, 1973.
2. Aleraj B: A study of the viral etiology of endemic nephropathy. In Cvoriscec D, Ceovic S, Stavljenic-Rukavina A eds: Endemic Nephropathy in Croatia. Academia Croatica Scientiarum Medicarum, Zagreb: 23-29, 1996.
3. Austwick PKC: Comparative aspects of renal disease. Proceedings of the Royal Society of Medicine 68: 219-222, 1975.
4. Belicza M and Vukelic M: Pathomorphology of endemic nephropathy. In Cvoriscec D, Ceovic S, Stavljenic-Rukavina A eds: Endemic Nephropathy in Croatia. Academia Croatica Scientiarum Medicarum, Zagreb: 39-41, 1996.
5. Bendele AM, Carlton MW, Krogh P et al : Ochratoxin A carcinoqenesis in the (C57GL/6J × C3H) F1 mouse. J Natl Cancer I 75: 733-742, 1985.
6. Bobinac E : First investigations of endemic nephropathy in the area of Brodska Posavina. In Cvoriscec D, Ceovic S, Stavljenic-Rukavina A eds: Endemic Nephropathy in Croatia. Academia Croatica Scientiarum Medicarum, Zagreb: 1-6, 1996.
7. Boorman G: Toxicology and carcinogenesis studies of ochratoxin A. US National Institutes of Health. Publication No 89-2813, Washington, 1989.
8. Borso G: Characteristics of clinical data on endemic nephropathy. In Cvoriscec D, Ceovic S, Stavljenic-Rukavina A eds: Endemic Nephropathy in Croatia. Academia Crostica Scientiarum Medicarum, Zagreb: 73-75, 1996.
9. Castegnaro M, Chernozemsky IN, Bartsch H: Meeting report: Endemic nephropathy and urinary tract tumors in the Balkans. Cancer Res 47: 3608-3609, 1987.
10. Ceovic J, Leko N, Bistrovic D: Endemic nephropathy treated at the Department of Medicine, Dr Josip Bencevic General Hospital, Slavonski Brod. In Cvoriscec D, Ceovic S, Stavljenic-Rukavina A eds: Endemic Nephropathy in Croatia. Academia Croatica Scientiarum Medicarum, Zabreb: 97-105, 1996.
11. Ceovic S, Hrabar A, Radonic M: Endemic nephropathy in different ethnic groups in the area of Slavonski brod. In Strahinjic S and Stefanovic V eds: Endemic (Balkan) Nephropathy: Proceedings of the 4th Symposium on Endemic Nephropathy. University Press, Nis: 229-232, 1979.
12. Ceovic S, Plestina R, Miletic-Medved M et al: Epidemiological aspects of Balkan endemic nephropathy in a typical focus in Yugoslavia. In Castegnaro M, Plestina R, Dirheimer G et al eds: Mycotoxins, Endemic Nephropathy and Urinary Tract Tumors. Scientific Publication 115, IARC, Lyon: 5-10, 1991.
13. Ceovic S, Hrabar A and Saric M: Epidemiology of Balkan endemic nephropathy. Food Chem Toxicol 30: 183-188, 1992.
14. Ceovic S and Miletic-Medved M: Epidemological features of endemic nephropathy in the focal area of Brodska Posavina, Croatia. In Cvoriscec D, Ceovic S, Stavljenic-Rukavina A eds: Endemic Nephropathy In Croatia. Academia Broatica Scientiarum Medicarum, Zagreb: 7-21, 1996.
15. Chernozemsky IN, Stoyanov IS, Petkova-Bocharova TK et al: Geographic correlation between the occurrence of endemic nephropathy and urinary tract tumors in Vratza district, Bulgaria. J Cancer 19: 1-11, 1977.
16. Chu FS: A comparative study of the interaction of ochratoxin with bovine serum a1bumin. Biochem Pharmacol 23: 1105-1113, 1974.
17. Creppy EE, Stormer FC, Kern D et al: Effects of ochratoxin A metabolites on yeast phenylalanyl-tRNA synthetase and on the growth and "in vivo" protein synthesis of hepatoma cells. Chem-Biol Interact 47: 239-247, 1983.
18. Cukuranovic R, Ignjatovic M, Stefanovic V: Urinary tract tumors and Balkan nephropathy in the South Morava River basin. Kidney Int 40 (Suppl 34): 80-85, 1991.
19. Cvetnic Z and Repeljnjak S: Ochratoxinogenicity of Aspergillus ochraceus strains from nephropathic and non-nephropathicareas of Yugoslavia. Mycopathologia 110: 93-99, 1990.
20. Cvoriscec D and Stavljenic-Rukavina A: Laboratory diagnosis of endemic nephropathy. In Cvoriscec D, Ceovic S, Stavljenic-Rukavina A eds: Endemic Nephropathy in Croatia. Academia Croatica Scientiarum Medicarum, Zagreb: 77-86, 1996.
21. Dimitrov Ts: Investigations of early stage of endemic nephropathy. PhD Thesis, ISUL, Sofia: 1970.
22. Dimitrov Ts: Balkan endemic nephropathy. Nedijaklov S ed. Bulgarian Academy of Sciences, Sofia, 1984.
23. Elling F: Morphological aspects of mycotoxic nephropathy. In Rodricks JV, Hesseltine CW, Mehlman MA eds: Mycotoxins in Human and Animal Health. Pathotox Publishers Inc, Illinois: 499-506, 1977.
24. Elling F: Demonstration of ochratoxin A in kidneys of pigs and rats by immunofluorescence microscopy. Acta Pathol Microb Scand Sect A 85: 151-156, 1997.
25. Elling F: Ochratoxin A - induced mycotoxic porcine nephropathy: Alterations in enzyme activity in tubular cells. Acta Pathol Microb Scand Sect A 87: 237-243, 1979.
26. Elling F: Ochratoxin A - induced porcine nephropathy: Stuctural changes and pathogenesis. Thesis DSR Forlag, Copenhagen: 1-32, 1981.
27. Elling F: Feeding experiments with ochratoxin A-contaminated barley to bacon pigs: IV renal lesions. Acta Agric Scand 33: 153-159, 1983.
28. Elling F, Nielsen JP, Lillehoj EB et al: Ochratoxin A-induced porcine nephropathy: Enzyme and ultrastructural changes after short-term exposure. Toxicon 23: 247-254, 1985.
29. Endo J: Effect of ochratoxin A on enzyme release from isolated nephron segments in rats. Proceeding of Japanese Association of Mycotoxicology 18, 1983.
30. Ferluga D, Hvala A, Vizjak A et al: Renal function, protein excretion, and pathology of Balkan endemic nephropathy. III: Light and electron microscope studies. Kidney Int 40 (Suppl 34): 57-67, 1991.
31. Ferluga D, Visjak A, Hvala A et al : A kidney biopsy study of early endemic nephropathy. In Cvoriscec D, Ceovic S, Stavljenic-Rukavina A eds: Endemic Nephropathy in Croatia. Academia Croatica Scientiarum Medicarum, Zagreb: 43-72, 1996.
32. Fuchs R, Radie B, Ceovic S et al: Human exposure to ochratoxin A. In Castegnaro M, Plestina R, Dirheimer G et al eds: Mycotoxins, Endemic Nephropathy and Urinary Tract Tumors. Scientific Publication 115, IARC, Lyon: 131-135, 1991.
33. Fuchs R and Hult K: Ochratoxin B in blood and its pharmacokinetic propterties. Food Chem Toxicol 30: 201-204, 1992.
34. Fuchs R and Radic B: Endemic nephropathy. In Cvoriscec D, Ceovic S, Stavljenic-Rukavina A eds: Endemic Nephropathy in Croatia. Academia Coratica Scientiarum Medicarum, Zabreb: 31-38, 1996.
35. Gubev E and Dinev I: Epidemological investigations in endemic nephropathy. Internal Disease 3: 118-121, 1972.
36. Hagelberg S, Fuchs R, Huit K: Toxicokinetics of ochratoxin A in several species and its plasma-binding properties. Journal Appl Toxicol 9: 91-96, 1989.
37. Hald B, Christensen DH and Krogh P: Natural occurrence of viomel lein in barley and the associated guinone-producing Penicillia. Appl Environ Microbiol 46: 1311-1317, 1983.
38. Hald B: Ochratoxin A in human blood in European countries. In Castegnaro M, Plestina R, Dirheimer G et al eds: Mycotoxins, Endemic Nephropathy and Urinary Tract Tumors. Scientific Publication 115, IARC, Lyon: 159-164, 1991.
39. Hald B: Porcine nephropathy in Europe. In Castegnaro M, Plestina R, Dirheimer G et al eds: Mycotoxins, Endemic Nephropathy and Urinary Tract Tumors. Scientific Publication 115, IARC, Lyon: 49-56, 1991.
40. Huit K and Fuchs R: Analysis and dynamics of ochratoxin A in biological systems. In Steyn S and Vleggaar R eds: Mycotoxins and Phycotoxins. VI International IUPAC Symposium on Mycotoxins and Phycotoxins, Pretoria 1985. Elsevier, Amsterdam: 365-376, 1985.
41. Hvala A, Kobeneter T, Ferluga D et al: Ultrastructure of tubular basement membrane and basement membrane of peritubular capillaries in Balkan endemic nephropathy. In: Proceedings of Multinational Congress on Electron Microscopy. University of Parma, Faculty of Engineering, Parma: 202-202, 1993.
42. IARC (International Agency for Research on Cancer): Ochratoxin A. In IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 31, Some Food Additives, Feed Additives and Naturally Occurring Substances: 191-206, 1983.
43. Kanisawa M, Suzuki S: Induction of renal and hepatic tumors in mice by ochratoxin A, a mycotoxin. Cann 69: 599-600, 1978.
44. KLaassen CD: Distribution, excretion and absorbtion of toxicants. In Klaassen CD, Amdur MO and Doull eds: Cassarett and Doull's Toxicology: The Basic Science of Poisons, 3rd Ed. Macmillian, New York: 33-66, 1986.
45. Lonstantinova L: Clinico-epidemiological investigations in emigrants from the regions with endemic nephropathy: PhD Thesis. Academic Press, Sofia: 1972.
46. Krogh P: Mycotoxic porcin nephropathy: A possible model for Balkan endemic nephropathy. In Puchlev A ed: Proceedings of the Second International Symposium on Endemic Nephropathy. Bulgarian Academy of Sciences, Sofia: 266-270, 1972.
47. Krogh P, Axelsen NH, Elling F et al: Experimental porcine nephropathy: Changes of renal function and structure induced by ochratoxin A-contaminated feed. Acta Pathol Microbiol Scand Sect A 246: 1-21, 1974.
48. Krogh P : Epidemiology of mycotoxic porcine nephropathy. Nord Veterinaermedicin 28: 452-458, 1976.
49. Krogh P, Hald B, Plestina R et al: Balkan (endemic) nephropathy and foodborne ochratoxin A: Preliminary results of a survey of foodstuffs. Acta Pathol Microbiol Scand Sect B 85: 238-240, 1977.
50. Krogh P: Causal associations of mycotoxic nephropathy. Acta Pathol Microbiol Scand Sect A 269: 1-28, 1978.
51. Krogh P, Gyrd-Hansen N, Hald B et al: Renal enzyme activities in experimental ochratoxin A-induced porcine nephropathy: Diagnostic potential of phospho-enolpyruvate carboxykinase and gamma-glutamyl transpeptidase activity. J Toxicol Environ Health 23: 1-14, 1988.
52. Krogh P: Role of ochratoxin A in disease causation. Food: Chem Toxicol 30: 213-224, 1992.
53. Kuiper-Goodman T and Scott PM: Risk assessment of the mycotoxin ochratoxin A. Biomed Environ Sci 2: 779-248, 1989.
54. Luster MI, Germolec DR, Burleson GR et al: Selective immuno-suppression in mice of natural killer cell activity by ochratoxin A. Cancer Res 47: 2259-2263, 1987.
55. Macanovic M, Rezakovic D, Basagic E et al: Endemic (Balkan) Nephropathy. The lancet: 541, 1976.
56. Manolova Y, Manolov C, Parvanova L et al: Induction of characteristic chromosomal aberrations, particularly X-trisomy, in cultured human lymphocytes treated by ochratoxin A, a mycotoxin implicated in Balkan endemic nephropathy. Mutatuin Res 231: 143-149, 1990.
57. Mantle PG and McHugh KM: Nephrotoxic fungi in foods from nephropathy households in Bulgaria. Mycol Res 97: 205-212, 1993.
58. Meisner H and Chan S: Ochratoxin A, an inhibitor of mitochondiral transport system. Biochemistry New York 13: 2795-2799, 1974.
59. Micco C, Miraglia M, Onori R et al: Effect of combined exposure to ochratoxin A and penicillic acid on residues and toxicity in broilers. La Ravista della Societa Itlaiana di Scienza dell' Allimentazione 20, 3: 101-108, 1991.
60. Nikolov IG and Chernozemsky IN: Balkan endemic nephropathy and transitional cell carcinoma: Two fatal chronic disease and the envrionment. Journal Environ Pathol Toxicol Oncol 10: 317-320, 1990.
61. The Nordic Working Group on Food Toxicology and Risk Evaluation (NNT): nordiske Seminar-og Arbeidsrapporter (1991: 545). Health Evaluation of Ochratoxin A in Food Products. Nordic Council of Ministers, Copenhagen: 1-29, 1991.
62. NTP: NTP Technical Report on the Toxicology and Carcinogenesis Studies of Ochratoxin A (Case No 303-47-9) in F344/N rats (Boorman G ed, Gavage Studies), NIH Publication No 89-2813. US Department of Health and Human Services, National Institutes of Health, Research Triangle Park, NC: 1989.
63. Parker RW, Phillips TD, Kubena LE et al: Inhibition of pancreatic carboxypeptidase A: A possible mechanism of interaction between penicillic acid and ochratoxin A. J Environ Sci Health B17: 77-91, 1982.
64. Pasare G, Melencu M. Lenkei R et al: The antibodies antienterobacteriaceae in endemic nephropathy. In Puchlev A ed: Proceedings of the Second International Symposium on Endemic Nephropathy. Bulgarian Academy of Sciences, Sofia: 242-246, 1972.
65. Pasare G, Pasare V, Melencu M et al: About a sterotype of pathogenous enterobacteriae isolated from urocultures and other products from endemic nephropathy patients. In Puchlev A ed: Proceedings of the Second International Symposium on Endemic Nephropathy. Bulgarian Academy of Sciences, Sofia: 231-236, 1972.
66. Pavlovic M, Plestina R and Krogh P: Ochratoxin A contamination of foodstuffs. Acta Pathol Microbiol Scand Sect B 87: 234-236, 1979.
67. Petkova-Bocharova T, Chernozemsky IN et al: Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary system tumors in Bulgaria. Food Addit Contam 5: 299-301, 1988.
68. Petkova-Bocharova T, Castegnaro M, Michelon J et al: Ochratoxin A and other mycotoxins in cereals from and area of Balkan endemic nephropathy and urinary tract tumors in Bulgaria. In Castegnaro M, Plestina R, Dirheimer G et al eds: Mycotoxins, Endemic Nephropathy and Urinary Tract Tumors. Scientific Publication 115, IARC, Lyon: 83-87, 1991.
69. Petkova-Bocharova T and Castegnaro M: Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary tract tumors in Bulgaria. In Castegnaro M, Plestina R, Dirheimer G et al eds: Mycotoxins, Endemic Nephropathy and Urinary Tract Tumors. Scientific Publication 115, IARC, Lyon: 135-137, 1991.
70. Plestina R, Ceovic S, Gatenbeck S et al: Human exposure to Ochratoxin A in areas of Yugoslavia with endemic nephropathy. J Environ Toxicol Oncol 10: 145-148, 1990.
71. Plestina R: Some features of Balkan endemic nephropathy. Food Chem Toxicology 30: 177-181, 1992.
72. Radovanovic S, Jankovic S and Jeremovic J: Incidence of tumors in urinary organs in focus of Balkan endemic nephropathy. Kidney Int 40 (Suppl 34): 75-77, 1991.
73. Raicevic S, Trnacevis S, Hranisavljevic J et al: Renal function, protein excretion, and pathology of Balkan endemic nephropathy. II: Protein excretion. Kidney Int 40 (Suppl 34): 52-56, 1991.
74. Steyn AF, Phillips TB, Kubena LF et al: Renal tubular secretion and reabsorption as factors in ochratoxicosis: Effects of probenecid on nephrotoxicity. J Toxicol Environ Health 16: 593-605, 1985.
75. Stoev SD: A Balkan endemic nephropathy (BEN) and its relation to the ochratoxicosis in swine. Veterinary Sci 27: 13-21, 1993.
76. Stoev SD and PEtrova-Bocharova TK: A possible role of ochratoxin A in a disease causation in connection with Balkan endemic nephropathy. In Proceedings of the 8th International Congress on Animal Hygiene. St Paul Minnesota: 61-64, 1994.
77. Stoev SD, Stojkov D, Petkova-Bocharova TK: Mycotoxin nephropathy (ochratoxicoslsj in swine. In Proceedings of the 8th International Congress on Animal Hygiene. St Paul, Minnesota: 100-103, 1994.
78. Stoev SD, Angelov G, Hald B: Hematological, biochemical and toxicological investigations in spontaneous mycotoxic nephropathy (ochratoxicosis) in Bulgarian pigs. XXV Congress of the World Veterinary Association. Abstracts, Yokohama: 268, 1995.
79. Stoev SD: Pathomorphological studies on spontaneous mycotoxic nephropathy in swine. Veterinary Medicine 2: 266-271, 1996.
80. Stoev SD, Grozeva N, Hald B: Ultrastructural and toxicological investigations in spontaneous cases of porcine nephropathy in Bulgaria. Veterinarski Arhiv 68: 39-493 1998.
81. Stoev SD, Stoeva J. Anguelov G et al: Hematological, biochemical and toxicological investigations in spontaneous cases with different frequency of porcine nephropathy in Bulgaria. J Vet Med Series A 45: 1998 (in press).
82. Stoev S: Experimental mycotoxic nephropathy in pigs. Pathomorphological studies. Vet Med 1-2: 102-107, 1997.
83. Stoev S, Hald B, Mantle P. Porcine nephropathy in Bulgaria: A progressive syndrome of complex of uncertain (mycotoxin) etiology. Vet Record 142: 190-194, 1998.
84. Stojkovic R, Hult K, Gamulin S et al: High affinity binding of ochratoxin A to plasma constituent. Biochern Int 9: 33-38, 1984.
85. Stoytchev I: Pathomorphological, epizootological and experimental investigations in animals in endemic area of Vratza regions: PhD Thesis. Academy of Medicine, Sofia: 2-32, 1981.
86. Suzuki S, Kozuka Y, Satoh T et al: Studies of the nephrotoxicity of ochratoxin A in tats. Toxicol Appl Pharm 34: 479-490, 1975.
87. Szczech GM, Carlton WW, Tuite J et al: Ochratoxin A toxicosis in swine. Vet Pathol 10: 347-364, 1973.
88. Trnacevic S, Halilbasic A, Ferluga D et al: Renal function, protein excretion and pathology of Balkan endemic nephropathy: I. Renal Function. Kidney Int 40 (Suppl 34): 49-51, 1991.
89. Van Edmond HP: Current situation on regulations of mycotoxins: Overview of tolerances and status of standard methods of sampling and analysis. Food Addit Contam 6: 139-188, 1989.
90. Vukelic M, Sostaric B and Belicza M: Pathomorphology of Balkan endemic nephropathy. Food Chem Toxicol 30: 193-200, 1992.